TITLE:
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

CONDITION:
Hypercholesterolemia

INTERVENTION:
Niacin extended release and simvastatin tablets

SUMMARY:

      The purpose of this study is to compare the effectiveness and safety of different doses of
      Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood
      (dyslipidemia).
    

DETAILED DESCRIPTION:

      The purpose of this study is to compare the efficacy and safety of different doses of Niacin
      ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).
    

ELIGIBILITY:
Gender: All
Age: 21 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patient has primary Type II hyperlipidemia or mixed dyslipidemia

          -  If the patient is currently taking anti-dyslipidemic medications other than Zocor,
             he/she is willing to withdraw from these medications

          -  Reasonable compliance with a standard cholesterol-lowering diet for a minimum of 4
             weeks prior to screening and for the duration of the study.

          -  LDL-C levels and/or Non HDL-C levels above normal for patients

        This study will be conducted both in the USA and internationally.

        Exclusion Criteria:

          -  Patient has an allergy, hypersensitivity, or intolerance to niacin, statins, or their
             derivatives

          -  HbA1c  9% in diabetic patients
      
